Remdesivir Shortages Plague Some Hospitals, Pharmacists Say
One-third of pharmacists report that they do not have enough remdesivir to treat all eligible patients
Delayed Treatment of Upper Respiratory Tract Infections Tied to Hospitalization Risk
However, delayed antibiotic prescribing was used similarly between high- and low-risk patients
School Closures Linked to Decreased COVID-19 Incidence, Death
Associations were largest in states with low cumulative incidence of COVID-19 at time of school closure
Excessive Drinking Responsible for 255 Deaths Per Day in U.S.
In addition, 29 years of life lost per death in the United States each year from 2011 to 2015
Risk for Heart Failure Increased for Women Taking β-Blockers
Difference of 4.6 percent found between women and men in rate of heart failure at presentation for ACS
COVID-19 Case Rates, Deaths Considerably Higher in Prisons
Case rate more than fivefold higher among prisoners versus U.S. population; death rate also higher
COVID-19-Related Symptoms Persist After Recovery
Only 12.6 percent of patients completely free of any COVID-19-related symptoms
Black Individuals at Increased Risk for SARS-CoV-2 Infection
Risk increased for infection and hospitalization, but not mortality, for Blacks versus non-Blacks
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
Pharma company says there is further evidence remdesivir may reduce deaths, hasten recovery
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
